The chemical class termed PLEKHS1 Activators encompasses a range of compounds that can influence the activity of the protein PLEKHS1 through various cellular signaling pathways. These activators are not directly tied to PLEKHS1 but engage in upstream or downstream processes that can lead to its activation. These compounds often interact with domains within proteins, such as the Pleckstrin Homology (PH) domain found in PLEKHS1, which is known to play a role in membrane association and interaction with phosphoinositides. Some activators function by binding to these domains, thereby altering the protein's conformation and its cellular localization, which can result in its activation. Others work by modulating the activity of enzymes that signal through pathways involving the PH domain, thereby indirectly influencing the activation state of PLEKHS1.
The diversity of this class is marked by their varied points of action within the cell. Some members of this group are recognized for their ability to inhibit or activate specific kinases, which in turn regulate phosphorylation events critical for the activation of many proteins, including those with PH domains. Others can change the concentration of secondary messengers such as calcium ions or diacylglycerol, which serve as pivotal molecules in the signaling cascades that can ultimately lead to the activation of PLEKHS1 by influencing the protein's interaction with other cellular components. Moreover, these activators can cause alterations in the lipid composition of cellular membranes, affecting the recruitment and function of PH domain-containing proteins. Through these varied mechanisms, the compounds classified as PLEKHS1 Activators can play significant roles in the regulation of PLEKHS1 without directly binding to the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could activate PLEKHS1 through phosphorylation events in related signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting PLEKHS1 through calcium-dependent signaling pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which could activate PLEKHS1 by modulating PKC and related signaling pathways. | ||||||
Calcium | 7440-70-2 | sc-252536 | 5 g | $209.00 | ||
As a secondary messenger, Ca2+ could activate PLEKHS1 by affecting numerous signaling pathways, including those potentially involving PLEKHS1. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
A sphingolipid metabolite that could activate PLEKHS1 by inhibiting PKC, which may alter signaling pathways involving PLEKHS1. | ||||||